RBC Capital analyst Natalia Webster raised the firm’s price target on Diaceutics (DIUXF) to 195 GBp from 165 GBp and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DIUXF:
- Diaceutics Director Increases Stake Signaling Confidence in Company Growth
- Diaceutics Enhances Employee Incentive Program with Share Awards
- Diaceutics Reports Strong FY 2024 Growth and Positive Outlook
- Diaceutics Opens New US Headquarters to Boost Market Presence
- Diaceutics Unveils Pathology Engagement Service with $1.8m Contract